Page last updated: 2024-10-25

cilostazol and Allodynia

cilostazol has been researched along with Allodynia in 2 studies

Research Excerpts

ExcerptRelevanceReference
" Cilostazol (CLZ) has pleiotropic effects including neuroprotection in several ravaging central disorders; nonetheless, its potential role in transient central ischemic-induced allodynia and hyperalgesia has not been asserted before."8.12Cilostazol Alleviates NLRP3 Inflammasome-Induced Allodynia/Hyperalgesia in Murine Cerebral Cortex Following Transient Ischemia: Focus on TRPA1/Glutamate and Akt/Dopamine/BDNF/Nrf2 Trajectories. ( Abdallah, DM; Mohammed, RA; Nassar, NN; Safar, MM; Zaki, OS, 2022)
" Cilostazol (CLZ) has pleiotropic effects including neuroprotection in several ravaging central disorders; nonetheless, its potential role in transient central ischemic-induced allodynia and hyperalgesia has not been asserted before."4.12Cilostazol Alleviates NLRP3 Inflammasome-Induced Allodynia/Hyperalgesia in Murine Cerebral Cortex Following Transient Ischemia: Focus on TRPA1/Glutamate and Akt/Dopamine/BDNF/Nrf2 Trajectories. ( Abdallah, DM; Mohammed, RA; Nassar, NN; Safar, MM; Zaki, OS, 2022)
"Co-treatment with cilostazol prevented paclitaxel-induced dedifferentiation of Schwann cell cultures and demyelination in a mixed culture of Schwann cells and dorsal root ganglia neurons."1.62Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation. ( Imai, S; Iwamitsu, Y; Koyanagi, M; Matsubara, K; Matsumoto, M; Moriya, A; Nakagawa, S; Nakagawa, T; Nakazato, Y; Ogihara, T; Saigo, M; Yonezawa, A, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Zaki, OS1
Nassar, NN1
Abdallah, DM1
Safar, MM1
Mohammed, RA1
Koyanagi, M1
Imai, S1
Iwamitsu, Y1
Matsumoto, M1
Saigo, M1
Moriya, A1
Ogihara, T1
Nakazato, Y1
Yonezawa, A1
Nakagawa, S1
Nakagawa, T1
Matsubara, K1

Other Studies

2 other studies available for cilostazol and Allodynia

ArticleYear
Cilostazol Alleviates NLRP3 Inflammasome-Induced Allodynia/Hyperalgesia in Murine Cerebral Cortex Following Transient Ischemia: Focus on TRPA1/Glutamate and Akt/Dopamine/BDNF/Nrf2 Trajectories.
    Molecular neurobiology, 2022, Volume: 59, Issue:12

    Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Carrier Proteins; Cerebral Cortex; Cilos

2022
Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
    Neuropharmacology, 2021, 05-01, Volume: 188

    Topics: Animals; Blood Proteins; Breast Neoplasms; Cell Dedifferentiation; Cell Line, Tumor; Cilostazol; Dem

2021